ライフサイエンスコーパス: load test

1 onducting horizontal low-cycle reciprocating load test.

2 ure but also had the highest number of viral load tests.

3 ure but also had the highest number of viral load tests.

4 urinary oxalate excretion during the oxalate load tests.

5 th HIV (PLWH) worldwide have access to viral load testing.

6 TI-based first-line ART to TLD without viral load testing.

7 f loss to follow-up; and point-of-care viral load testing.

8 that use alternatives to plasma-based viral load testing.

9 ing transition to TLD without previous viral load testing.

10 ine human immunodeficiency virus (HIV) viral load testing.

11 when compared with standard laboratory viral load testing.

12 sessed with WHO criteria, confirmed by viral-load testing.

13 confirmation, followed by HIV-1 plasma viral load testing.

14 iation of ART with targeted or routine viral load testing.

15 igital PCR (ddPCR) for cytomegalovirus (CMV) load testing.

16 an assay for the clinical application of HCV load testing.

17 onal reagents that can be used for CMV viral load testing.

18 y an attractive option for routine HCV viral load testing.

19 mmunosorbent assay and repeated plasma viral load testing.

20 ection was falsely diagnosed by plasma viral load testing.

21 ive human immunodeficiency virus (HIV) viral-load testing.

22 onism was confirmed by using the oral sodium-loading test.

23 ting and genotyping, and quantitative (viral load) testing.

24 transplant recipients who underwent a water-loading test 3 months after transplant to determine osmo

25 presented for their first routine HIV viral load test 6 months after ART initiation.

26 ibody-reactive patients, 435 completed viral load testing (82%), of whom 301 (69%) were chronically i

27 performed using HIV diagnostic assays, viral load testing, a single-copy RNA assay, and HIV genotypin

28 well compared to a market-leading HCV viral load test and should be considered for instances where r

29 ines have been useful in ensuring that viral-load testing and combination therapy is widely available

30 t recommendation (GRT group) or repeat viral-load testing and empirical onward treatment (usual care

31 e, we review the current challenges of viral load testing and present the case for greater utilizatio

32 Africa, often in the absence of recent viral load testing and without access to genotypic resistance

33 t, prompt adherence support with rapid viral load testing, and patient-centred, flexible clinic acces

34 g on patients with advanced HIV, rapid viral load testing, and routine access to drug resistance test

35 IMD(0), GES, water load testing, and symptoms were then compared in 177 pat

36 d with standardization of quantitative viral load testing are discussed in relation to human cytomega

37 ounts and human immunodeficiency virus (HIV) load testing are essential components of HIV care, and m

38 g data of human immunodeficiency virus (HIV) load testing are pivotal to limiting the threat of HIV d

39 ettings where both CD4 cell counts and viral load testing are routinely available, countries should c

40 ients, which will be vital in ensuring viral load tests are appropriately used to improve the quality

41 We optimized the interval between viral load tests as a function of patients' age, gender, educa

42 quence to receive either point-of-care viral load testing at enrolment and after 6 months with task s

43 e mode is not observed in comparative static loading tests, attesting to a strong mechanical componen

44 s been widely implemented for clinical viral load testing, but a lack of standardization and relative

45 IMPLICATIONS: The Xpert HCV Viral Load test can detect active infection from a finger-stic

46 Point-of-care viral load testing combined with task shifting significantly i

47 tings, and there is no appropriate HIV viral load test currently available at the point-of-care in lo

48 were retained in care with a 12-month viral load test done, viral suppression was higher with AZT/XT

49 copies/mL) using leftover plasma after viral load testing during September 2017-January 2018.

50 copies/mL) using leftover plasma after viral load testing during September 2017-January 2018.

51 entation of pooled testing to increase viral load testing efficiency at a reference laboratory in Cam

52 re 5 monitoring schemes to the current viral load testing every 6 months and every 12 months.

53 five monitoring schemes to the current viral load testing every six months and testing every 12 month

54 ivity and specificity of the Xpert HCV Viral Load test for HCV RNA detection by venepuncture and fing

55 ration technologies to serve as an HIV viral load test for low-resource settings.

56 Whether viral load testing for children with HIV is necessary to infor

57 Viral load testing for cytomegalovirus (CMV) has become the st

58 Viral load testing for hepatitis C virus (HCV) RNA has become

59 Scaling up access to HIV viral load testing for individuals undergoing antiretroviral t

60 Current viral load tests for human immunodeficiency virus (HIV) can on

61 n BioRobot is described for performing viral load tests for human immunodeficiency virus (HIV) with t

62 CD4 and viral load tests for patients receiving HIV care from the US D

63 However, no viral load test has been approved by the FDA.

64 While viral load testing has gained widespread acceptance, a primary

65 ting (HIV-negative partner), and HIV-1 viral load testing (HIV-positive partner).

66 improve interlaboratory agreement for viral load testing; however, insufficient data are available t

67 ss these issues and increase access to viral load testing; however, their technical performance is un

68 imated 77% of eligible people accessed viral load testing in 2022, due to barriers including the high

69 epresents a convenient alternative for viral load testing in a clinical setting.

70 to the assessment of Epstein-Bar virus (EBV) load testing in four quantitative PCR assays, treating d

71 se findings can also promote access to viral load testing in resource-limited settings for all people

72 This may support improved access to viral load testing in resource-limited settings lacking the re

73 Glutamine loading tests in two fibroblast cultures from two relate

74 potential to reduce the variability in viral load testing introduced by differences in LDTs.

75 Viral load testing is an essential parameter in guiding antire

76 Accurate routine HIV viral load testing is essential for assessing the efficacy of

77 HIV-1 viral load testing is essential to the management of HIV-1-inf

78 HIV-1 viral load testing is recommended to monitor antiretroviral th

79 HIV on antiretroviral therapy, routine viral load testing is recommended to monitor treatment effecti

80 HIV-1 RNA quantitation in plasma, or virus load testing, is the primary method by which the respons

81 f plasma specimens is the standard for viral load testing, its use is restricted by the limited ambie

82 ies that have just started to scale up viral load testing, lessons can be learnt from countries such

83 rsal access to quality care, including viral load testing; leverage community leadership to address s

84 international standards, quantitative viral load testing of transplant-associated viruses continues

85 are fabricated with 3D printing and a cyclic loading test of the printed materials captures a great m

86 to an oral glucose test (OGTT) and oral fat load test (OFTT) in the EARSII group of young, healthy m

87 se events related to point-of-care HIV viral load testing or task shifting.

88 r an overnight fast and after an acute water-load test performed before oxcarbazepine exposure and af

89 immunodeficiency virus type 1 (HIV-1) viral load testing, plasma HIV-1 RNA levels were quantitated w

90 equately addressed, the full impact of viral load testing regarding clinical management decisions wil

91 ring HIV care with a CD4 cell count or viral load test result by calendar period, as well as the prop

92 re and receiving ART with at least one viral load test result.

93 treatment for EBV and BKV is driven by viral load test results, and the more accurate and comparable

94 nd July 27, 2016, 150 participants had viral load testing results for the three assays tested.

95 trations (n = 6,115) and tetrahydrobiopterin loading test results (n = 4,381), enabling prediction of

96 Stress loading tests revealed that these polarized dynamics res

97 es (intervention group), or laboratory viral load testing (standard-of-care group).

98 ting SHM system was carried out by the field load testing (Static and dynamic) of the bridge.

99 CoOOH@BSA-FITC nanoprobe-loaded test strips enabled quick ASA detection in intact

100 specimens analyzed with commonly used viral load testing technologies.

101 e suppression of hyperglycaemia in a maltose loading test than miglitol, a drug presently used in the

102 he potential benefits of point-of-care viral load tests that may become available in the future.

103 r drug-adherence and limited access to viral load testing, the current standard for treatment-monitor

104 Among mothers with viral load testing, the lowest level associated with transmiss

105 w-up, or who were in follow-up without viral load testing, the proportion of children and adolescents

106 ed on the low frequency cyclic (LFC) tensile loading tests, the inherent magnetism was fully describe

107 ted risk for illness immediately after viral load testing; this predictive relation attenuated over t

108 Viral-load testing through 52 weeks can identify all children

109 aulter tracing and scale-up of routine viral load testing to identify patients failing first-line ART

110 rules (Westgard rules) are applied to viral load testing to identify runs that should be reviewed or

111 tudy was to assess whether introducing viral load testing to inform new nucleoside or nucleotide reve

112 sed dramatically over the past decade, viral load testing to monitor the response of patients receivi

113 es discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and

114 ticularly if there is scarce access to viral load tests to monitor treatment outcomes.

115 eening and CD4 counts, and in-parallel viral load testing, to promote fast and complete diagnosis and

116 14 of 1838 with at least two viral load tests upon transitioning had viral failure (all wit

117 e-up of dried blood spot specimens for viral load testing using the same 1,000 copies/ml treatment fa

118 The Brazil nuts were subjected to axial-loading tests using various inclinations (precrack angle

119 3) transition to dolutegravir based on viral load testing (viral load plus dolutegravir), keeping cur

120 1 (HIV-1) Monitor (version 1.5; Roche) viral load test was tested.

121 Viral load testing was done in all HIV-infected participants,

122 Viral load testing was only consistently available starting in

123 casions, a 9-h oral [(13)C]-labeled fructose loading test was performed on the fifth day to measure [

124 via fluid flow simulations and polymer bead loading tests, we trapped Aiptasia larvae containing alg

125 mittee and laboratory staff conducting viral-load testing were.

126 Methionine-loading tests were conducted at baseline and week 14.

127 Oxalate load tests, which entailed the ingestion of a 63-mg dose

128 to determine whether point-of-care HIV viral load testing with task shifting changed treatment and ca

129 to uniaxial tensile, relaxation, and cyclic loading testing with the use of an automated load cell u

130 nd metabolic syndrome, underwent an oral fat load test, with measurement of plasma triglyceride-rich

131 th African guidelines recommend repeat viral load testing within 6 months when human immunodeficiency

132 significantly decreased the number of viral load tests without markedly increasing the number of mon

133 All three plasma viral load tests yielded positive results with low values (125